Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Income from Continuing Operations (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Income from Continuing Operations for 5 consecutive years, with 14363000.0 as the latest value for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 28.96% year-over-year to 14363000.0; the TTM value through Dec 2025 reached 55312000.0, up 33.94%, while the annual FY2025 figure was 54663000.0, 34.72% up from the prior year.
  • Income from Continuing Operations hit 14363000.0 in Q4 2025 for Kezar Life Sciences, down from 10689000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 10689000.0 in Q3 2025 and bottomed at 32260000.0 in Q4 2023.
  • Average Income from Continuing Operations over 5 years is 18189350.0, with a median of 17201500.0 recorded in 2022.
  • Year-over-year, Income from Continuing Operations crashed 77.44% in 2023 and then soared 47.38% in 2025.
  • Kezar Life Sciences' Income from Continuing Operations stood at 14212000.0 in 2021, then dropped by 27.93% to 18181000.0 in 2022, then plummeted by 77.44% to 32260000.0 in 2023, then soared by 37.33% to 20218000.0 in 2024, then rose by 28.96% to 14363000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 14363000.0, 10689000.0, and 13704000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.